Pacific Biosciences Of California, Inc. (NASDAQ: PACB)

Pacific Biosciences Of California, Inc. is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions enabling scientists and clinical researchers to improve their understanding of the genome and resolve genetically complex problems. The company's core offerings include its HiFi long read sequencing technology, which delivers highly accurate, long reads for applications such as human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging areas.

Pacific Biosciences Of California, Inc. generates revenue primarily through the sale of its sequencing instruments, consumables, and related services. The company sells systems such as the Revio, Vega, and Sequel platforms, along with proprietary consumables including SMRT cells, reagent kits for library preparation, binding, sequencing, and specialized applications like Kinnex and PureTarget panels. Additionally, it provides application specific workflows and support services to its customers.

Pacific Biosciences Of California, Inc. holds a competitive position in the nucleic acid sequencing market, facing rivals such as Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, Roche, Qiagen, Element Biosciences, Bionano Genomics, Ultima Genomics, and 10x Genomics. Its differentiation lies in the high accuracy and long read lengths of its HiFi technology, which enables detection of structural variants, epigenetic modifications, and full length transcripts that short read platforms often miss. The company's ability to deliver multi omic data from a single workflow further strengthens its appeal to research and clinical customers seeking comprehensive genomic insight.

The company serves a diverse customer base that includes academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, pharmaceutical companies, and agricultural companies. These customers use PacBio systems to perform sequencing in house or send samples to third party service providers that utilize the company's technology and return data for downstream analysis.